证券日报网讯 8月13日晚间，海利尔发布公告称，公司董事会于近日收到公司董事毛志建先生递交的书 面辞职报告。因公司内部工作调整，毛志建先生申请辞去公司第五届董事会董事职务。辞去上述职务 后，毛志建先生将继续在公司担任其他职务。公司于2025年8月13日召开2025年第一次职工代表大会， 选举陈萍先生为公司第五届董事会职工代表董事，任期自本次职工代表大会审议通过之日起至公司第五 届董事会届满之日止。 （文章来源：证券日报） ...

证券代码：603639 证券简称：海利尔 公告编号：2025-039 海利尔药业集团股份有限公司 为保障公司董事会正常运作，根据《公司法》《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等法律法规、规范 性文件以及《公司章程》等相关规定，公司于 2025 年 8 月 13 日召开 2025 年第一次 职工代表大会，选举陈萍先生为公司第五届董事会职工代表董事（简历详见附件）， 任期自本次职工代表大会审议通过之日起至公司第五届董事会届满之日止。 陈萍先生当选公司职工代表董事后，公司第五届董事会中兼任公司高级管理人 员以及由职工代表担任的董事人数总计未超过公司董事总数的二分之一，符合相关 法律法规的要求。 特此公告。 海利尔药业集团股份有限公司董事会 2025 年 8 月 14 日 附件： 关于公司董事辞任暨选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 海利尔药业集团股份有限公司（以下简称"公司"）董事会于近日收到公司董 事毛志建先生递交的书面辞职报告。因公司内部 ...

海利尔公告，公司董事毛志建因内部工作调整，辞去公司第五届董事会董事职务。毛志建将继续在公司 担任其他职务。公司第五届董事会职工代表董事选举陈萍为新任职工代表董事，任期至第五届董事会届 满之日止。陈萍，1979年3月生，学历大专，曾任青岛海利尔药业有限公司出纳、货运部部长、行政部 部长，现任海利尔药业集团股份有限公司总裁助理、青岛大护农业科技有限公司总经理。 ...

Group 1 - The company has products, specifically the raw materials imidacloprid and thiamethoxam, that have a certain effectiveness in killing mosquitoes [2] - The Qingdao Hengning project, which will produce 1,500 tons of thiamethoxam annually, is set to enter trial production in December 2024 [2] - The combined sales revenue from imidacloprid and thiamethoxam raw materials is expected to account for less than 10% of the company's total revenue in 2024 [2]

Group 1 - The company is actively engaged in research and promotion of biopesticides and fertilizers [2]

Core Viewpoint - The company Hai Li Er (603639.SH) has indicated that its raw materials, imidacloprid and thiamethoxam, have a certain insecticidal effect on mosquitoes, but it currently does not have any specialized mosquito control formulations [1] Group 1 - The company is set to begin trial production of its 1,500 tons per year thiamethoxam project in Qingdao Hengning by December 2024 [1] - The combined sales revenue from imidacloprid and thiamethoxam raw materials is expected to account for less than 10% of the company's total revenue in 2024 [1] - The company does not currently offer any specific products aimed at mosquito extermination [1]

Market Performance - The agricultural chemical sector increased by 0.36% on August 4, with Bai'ao Chemical leading the gains [1] - The Shanghai Composite Index closed at 3583.31, up 0.66%, while the Shenzhen Component Index closed at 11041.56, up 0.46% [1] Top Gainers in Agricultural Chemicals - Bai'ao Chemical (603360) closed at 21.09, up 5.24% with a trading volume of 217,900 shares and a turnover of 457 million [1] - Limin Co., Ltd. (002734) closed at 21.27, up 4.93% with a trading volume of 578,200 shares and a turnover of 1.204 billion [1] - Other notable gainers include ST Huifeng (002496) at 1.70 (+2.41%), Guomi Co., Ltd. (002749) at 15.51 (+2.38%), and Stanley (002588) at 9.17 (+2.34%) [1] Top Losers in Agricultural Chemicals - Yab Chemical (300261) closed at 8.42, down 2.66% with a trading volume of 758,800 shares and a turnover of 631 million [2] - Hongtaiyang (000525) closed at 7.03, down 1.68% with a trading volume of 269,200 shares and a turnover of 189 million [2] - Other notable losers include Hualu Hengsheng (600426) at 23.48 (-1.51%) and Xin'an Chemical (600596) at 9.87 (-1.30%) [2] Capital Flow Analysis - The agricultural chemical sector saw a net inflow of 37.9765 million from institutional investors, while retail investors experienced a net outflow of 4.3928 million [2] - Limin Co., Ltd. (002734) had a significant net inflow of 98.972 million from institutional investors, but a net outflow of 78.3473 million from retail investors [3] - Bai'ao Chemical (603360) also experienced a net inflow of 58.5788 million from institutional investors, with a net outflow of 12.7147 million from retail investors [3]

Core Viewpoint - The company plans to repurchase and cancel 20,000 restricted stocks due to certain incentive recipients no longer meeting the eligibility criteria outlined in the 2021 restricted stock incentive plan [2][4]. Group 1: Repurchase and Cancellation Details - The decision for the repurchase and cancellation of restricted stocks was approved during the fifth board meeting on April 28, 2025, following the authorization from the first extraordinary general meeting of shareholders in 2021 [2][4]. - The repurchase involves 6 incentive recipients who will have their unvested restricted stocks canceled [5]. - The company has opened a dedicated securities account for the repurchase and submitted the application for cancellation, expecting to complete the process by August 1, 2025 [5]. Group 2: Legal and Compliance Aspects - The board confirms that the decision-making process and information disclosure comply with relevant laws and regulations, ensuring no harm to the rights of incentive recipients or creditors [7]. - A legal opinion from a law firm confirms that the repurchase has obtained necessary authorizations and complies with applicable laws and regulations [7].

证券代码：603639 证券简称：海利尔 公告编号：2025-038 海利尔药业集团股份有限公司 关于股权激励限制性股票回购注销实施的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：根据公司 2021 年限制性股票激励计划相关规定，公司部 分激励对象已不符合激励条件，公司拟对该激励对象已获授但尚未解锁的限制性 股票进行回购注销。 本次注销股份的有关情况： | 回购股份数量 | 注销股份数量 | 注销日期 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 20,000 | 股 | 20,000 | 股 | 2025 | 年 | 8 | 月 | 1 | 日 | 一、本次限制性股票回购注销的决策与信息披露 根据公司 2021 年第一次临时股东大会的授权，2025 年 4 月 28 日，公司召 开第五届董事会第八次会议和第五届监事会第八次会议，审议通过《关于回购注 销部分激励对象已获授但尚未 ...

北京市金杜（青岛）律师事务所 关于海利尔药业集团股份有限公司 2021 年限制性股票激励计划回购注销部分已授予限制性股票事项的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）受海利尔药业集团 股份有限公司（以下简称海利尔或公司）委托，作为其 2021 年限制性股票激励计 划（以下简称本次股权激励计划或本计划）的专项法律顾问。本所根据《中华人 民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证 券法》）、中国证券监督管理委员会（以下简称中国证监会）《上市公司股权激励管 理办法》（以下简称《管理办法》）1等法律、行政法规、部门规章及规范性文件（以 下简称法律法规）和《海利尔药业集团股份有限公司章程》（以下简称《公司章程》） 的有关规定，以及公司于 2021 年 3 月 6 日公告的《海利尔药业集团股份有限公司 2021 年限制性股票激励计划（草案）》（以下简称《限制性股票激励计划》），就公 司本次回购注销部分已授予限制性股票（以下简称本次回购注销）所涉及的相关 事宜出具本法律意见书。 为出具本法律意见书，金杜依据《律师事务所从事证券法律业 ...